Company Profile

KILITCH DRUGS (INDIA) LTD., ESTABLISHED IN 1978, IS A WHO-GMP-CERTIFIED PHARMACEUTICAL MANUFACTURER, DISTRIBUTOR, AND CERTIFIED 3-STAR EXPORT HOUSE WITH NEARLY FIVE DECADES OF EXCELLENCE IN DELIVERING TRUSTED HEALTHCARE SOLUTIONS WORLDWIDE. WITH FIVE MODERN MANUFACTURING UNITS, 10 GLOBAL SALES OFFICES, AND OPERATIONS ACROSS 47+ COUNTRIES, KILITCH HAS BUILT LONG-TERM PARTNERSHIPS WITH OVER 155 CLIENTS AND REGISTERED MORE THAN 475 PRODUCTS, WHILE SUCCESSFULLY SUPPLYING 3.2+ BILLION UNITS ACROSS DIVERSE THERAPEUTIC SEGMENTS INCLUDING ANTI-MALARIALS, ANTIBIOTICS, CRITICAL CARE, CARDIOVASCULAR, GASTROINTESTINAL, AND CNS FORMULATIONS. BACKED BY A STRONG REGULATORY AFFAIRS TEAM AND END-TO-END DOSSIER SUPPORT, KILITCH SPECIALIZES IN CUSTOM FORMULATIONS AND CMO/CDMO SERVICES, ENSURING COMPLIANCE, QUALITY, AND RELIABILITY. HAVING ACHIEVED $603 MILLION IN CUMULATIVE REVENUE, THE COMPANY CONTINUES TO FOCUS ON INNOVATION, GLOBAL MARKET EXPANSION, AND HUMAN-CENTRIC PARTNERSHIPS.